ADC Therapeutics SA: net income or loss
Net income or loss for ADC Therapeutics SA. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ADC Therapeutics SA financial histories
What this measure means
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
Exact concept: us-gaap:NetIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -142,623,000 | USD | 2026-03-10 | 10-K · 0001628280-26-016491 |
| 2024-01-01 | 2024-12-31 | -157,846,000 | USD | 2026-03-10 | 10-K · 0001628280-26-016491 |
| 2023-01-01 | 2023-12-31 | -240,053,000 | USD | 2025-03-27 | 10-K · 0001628280-25-015131 |
| 2022-01-01 | 2022-12-31 | -157,128,000 | USD | 2024-03-13 | 10-K · 0001628280-24-010843 |
Related financial histories
- ADC Therapeutics SA: total assets
- ADC Therapeutics SA: total liabilities
- ADC Therapeutics SA: stockholders equity
- ADC Therapeutics SA: cash and cash equivalents
- ADC Therapeutics SA: operating cash flow
- ADC Therapeutics SA: capital expenditure payments
- ADC Therapeutics SA: revenue
- ADC Therapeutics SA: financing cash flow
- ADC Therapeutics SA: investing cash flow
- ADC Therapeutics SA: retained earnings or deficit
- ADC Therapeutics SA: basic weighted-average shares
- ADC Therapeutics SA: diluted weighted-average shares
- ADC Therapeutics SA: basic earnings per share
- ADC Therapeutics SA: diluted earnings per share
- ADC Therapeutics SA: income tax expense or benefit
- ADC Therapeutics SA: net property, plant and equipment
- ADC Therapeutics SA: share-based compensation expense
- ADC Therapeutics SA: operating income or loss
- ADC Therapeutics SA: current assets
- ADC Therapeutics SA: interest expense
- ADC Therapeutics SA: current liabilities
- ADC Therapeutics SA: current accounts payable
- ADC Therapeutics SA: net inventory
- ADC Therapeutics SA: cost of revenue
- ADC Therapeutics SA: research and development expense
Inspect the source
- Entity
- ADC Therapeutics SA / CIK 0001771910
- Captured
- 2026-09-21T17:26:51.265Z
- SEC response SHA-256
be21fbcb263f7107bfa82b6dbe3dc5cfd8b04ce8fdd22a4e11c940599a394319
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001771910.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))